The expression of PAI-1 as well as the phosphorylation of FAK was inhibited in tumors treated with IMD-4482 compared with controls, suggesting that IMD-4482 inhibited the progression of ovarian cancer by inhibiting the phosphorylation of FAK in cancer cells. This evidence concerns the gene PTK2 and ovarian cancer.